عند القبول MB مساهمة قياس تركيز كتلة كرياتين كيناز في التشخيص المبكر لاحتشاء العضلة القلبية الحاد خبرة مشفى الأسد الجامعي باللاذقية
Abstract
وتحليل تنبؤي حساس ونوعي في تشخيص(CK-MB) MB تم تطوير مقايسة سريعة للكرياتين كيناز احتشاء العضلة القلبية في الساعات 6-12 الأولى بعد بدء الألم الصدري.
إن هذه الطريقة استخدمت عند 37 مريضاً قدموا إلى قسم الإسعاف في مشفى الأسد الجامعي باللاذقية بشكوى ألم صدري لم يمض عليه أكثر من6 ساعات, وذلك بين عامي 2006-2007.
جمعت عينات الدم في الساعة 1و4و8و12 بعد وصول المريض لقسم الإسعاف، ثم تم تحليل العينات لعيار
.CK-MB ثم وضع تشخيص احتشاء العضلة القلبية أو استبعاده بناءً على مقاربة نتائج تحليل CK-MB
قيِمت نتائج الدراسة المستخلصة للمرضى السابقين وكانت المحصلة:
- 28 مريضاً (75.67%) كان الاختبار سلبي عندهم، 17 مريضاً خرج للمنزل بأمان و 11 مريض شخص لديهم خناق صدر غير مستقر وخضعوا لمعالجة وريدية بالهيبارين والنترات.
- 9 مرضى (24.32%) كان الاختبار إيجابي عندهم، شخصAMI عند 8 مرضى وتلقى 7 منهم معالجة حالة للخثرة، واستبعد وجود AMI عند مريض واحد وخرج للمنزل.
A rapid assay of creatine kinase MB (CK-MB) was developed and its sensitivity and specificity analyzed in diagnosis myocardial infraction (MI) in the first six - twelve hours after the onset of chest pain. The method used on 37 patients who were admitted to the emergency rooms at the Al-assad University Hospital in Lattakia between 2006- 2007, with chest pain of less than six hours. Blood samples were collected in the first hour and 4,8,12 hours after the admission to the emergency room.
The samples were analyzed for CK-MB, and the diagnosis of myocardial infraction was confirmed by conventional CK-MB analysis.
Results of the 37 patients evaluated were:
- The method was negative in 28 patients; 17 patients sent home safely, 11 patients had USA and they had intravenous therapy with heparin and nitrate.
- The method was positive in 9 patients, 8 had AMI; 7 of them had thrombolysis; 1 patient was sent home, and ruled out of AMI.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.